| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |